OncoCyte Debt to Equity Ratio 2014-2024 | OCX

Current and historical debt to equity ratio values for OncoCyte (OCX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. OncoCyte debt/equity for the three months ending September 30, 2024 was 0.00.
OncoCyte Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $0.06B $0.01B 6.23
2024-06-30 $0.05B $0.02B 2.29
2024-03-31 $0.06B $0.01B 5.13
2023-12-31 $0.05B $0.02B 2.66
2023-09-30 $0.04B $0.04B 1.17
2023-06-30 $0.04B $0.04B 1.01
2023-03-31 $0.05B $0.04B 1.18
2022-12-31 $0.07B $0.03B 1.92
2022-09-30 $0.08B $0.08B 1.05
2022-06-30 $0.09B $0.08B 1.06
2022-03-31 $0.09B $0.06B 1.57
2021-12-31 $0.09B $0.07B 1.45
2021-09-30 $0.07B $0.10B 0.69
2021-06-30 $0.08B $0.10B 0.73
2021-03-31 $0.02B $0.11B 0.21
2020-12-31 $0.02B $0.03B 0.66
2020-09-30 $0.02B $0.04B 0.67
2020-06-30 $0.02B $0.04B 0.60
2020-03-31 $0.02B $0.04B 0.63
2019-12-31 $0.01B $0.03B 0.29
2019-09-30 $0.00B $0.03B 0.12
2019-06-30 $0.00B $0.03B 0.12
2019-03-31 $0.00B $0.04B 0.09
2018-12-31 $0.01B $0.00B 1.78
2018-09-30 $0.01B $0.01B 0.72
2018-06-30 $0.01B $0.01B 0.78
2018-03-31 $0.01B $0.01B 0.73
2017-12-31 $0.01B $0.00B 1.32
2017-09-30 $0.01B $0.01B 0.77
2017-06-30 $0.01B $0.01B 1.15
2017-03-31 $0.01B $0.01B 0.73
2016-12-31 $0.01B $0.01B 0.47
2016-09-30 $0.00B $0.01B 0.33
2016-06-30 $0.00B $0.00B 0.66
2016-03-31 $0.00B $0.01B 0.40
2015-12-31 $0.00B $0.01B 0.22
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.00B 0.00
2015-03-31 $0.00B $0.00B 0.00
2014-12-31 $0.01B $-0.00B -5.90
2013-12-31 $0.01B $0.00B 1.29
Sector Industry Market Cap Revenue
Medical Medical Services $0.037B $0.002B
OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.995B 10.55
Cencora (COR) United States $43.734B 16.44
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $20.871B 0.00
ICON (ICLR) Ireland $16.879B 15.03
Viatris (VTRS) United States $14.478B 4.46
Avantor (AVTR) United States $14.307B 21.45
Revvity (RVTY) United States $13.453B 23.37
BioMerieux (BMXMF) France $12.659B 0.00
CochLear (CHEOY) Australia $11.807B 0.00
Solventum (SOLV) United States $11.540B 0.00
Medpace Holdings (MEDP) United States $10.417B 29.35
Doximity (DOCS) United States $10.302B 60.64
Charles River Laboratories (CRL) United States $9.314B 18.00
HealthEquity (HQY) United States $8.212B 41.20
Sonic Healthcare (SKHHY) Australia $8.208B 0.00
Bausch + Lomb (BLCO) Canada $6.322B 29.43
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.759B 20.11
Organon (OGN) United States $3.719B 3.75
BrightSpring Health Services (BTSG) United States $2.967B 63.11
Surgery Partners (SGRY) United States $2.493B 28.42
Concentras Parent (CON) United States $2.491B 0.00
Ardent Health Partners (ARDT) United States $2.291B 0.00
GeneDx Holdings (WGS) United States $2.069B 0.00
Premier (PINC) United States $2.067B 10.76
PACS (PACS) United States $1.992B 0.00
Alignment Healthcare (ALHC) United States $1.969B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.730B 0.00
GoodRx Holdings (GDRX) United States $1.711B 44.90
Teladoc Health (TDOC) United States $1.544B 0.00
Pediatrix Medical (MD) United States $1.224B 11.98
Progyny (PGNY) United States $1.208B 24.47
Embecta (EMBC) United States $1.161B 8.12
CareDx (CDNA) United States $1.102B 0.00
Establishment Labs Holdings (ESTA) $1.090B 0.00
AMN Healthcare Services Inc (AMN) United States $0.874B 5.91
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.775B 0.00
SBC Medicals (SBC) United States $0.649B 0.00
Auna S.A (AUNA) Luxembourg $0.492B 0.00
InnovAge Holding (INNV) United States $0.478B 0.00
DocGo (DCGO) United States $0.444B 16.73
Sonida Senior Living (SNDA) United States $0.441B 0.00
Enhabit (EHAB) United States $0.387B 33.48
Sera Prognostics (SERA) United States $0.275B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.268B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Biodesix (BDSX) United States $0.198B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
ModivCare (MODV) United States $0.156B 8.44
MultiPlan (MPLN) United States $0.108B 0.00
Ascend Wellness Holdings (AAWH) United States $0.099B 0.00
So-Young (SY) China $0.093B 15.69
IceCure Medical (ICCM) Israel $0.052B 0.00
Singular Genomics Systems (OMIC) United States $0.050B 0.00
NeueHealth (NEUE) United States $0.033B 0.87
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Cano Health (CANOQ) United States $0.001B 0.00
Aclarion (ACON) United States $0.001B 0.00